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Rates of human papillomavirus (HPV) infection are highest in young adults, who can be vaccinated against HPV
if they were not vaccinated as adolescents. Since young adults increasingly access health information on social
media, we tested the impact of a social media campaign with narrative-based health information on intentions
related to HPV vaccination. We also aimed to understand which ads resonated most with young adults and led to
higher survey completion rates. We created social media posts featuring videos promoting HPV vaccination. We
launched a sponsored ad campaign on Facebook to reach young women, ages 18–26, across the country. Par
ticipants were randomly assigned one of 6 videos and then completed a brief survey about video engagement and
intentions to: talk with a health care professional, talk with friends or family, and vaccinate against HPV. A
descriptive correlational design and a test for moderation were used to explore hypothesized relationships.
Across all ads, 1332 link clicks led to 991 completed surveys that were reduced to 607 surveys (95 % ages 18–26,
63 % non-Caucasian; 58 % sexually active). Higher video engagement was associated with stronger intentions to
talk with a health care professional (r = 0.44, p =.01), talk with friends/family (r = 0.52, p =.01), and vaccinate
against HPV (r = 0.43, p =.01). Young adults were receptive to watching narrative-based health information
videos on social media. When promoting HPV vaccination, more engaging information leads to greater intentions
to talk about the vaccine and get vaccinated.

1. Background
1.1. Human papillomavirus and the vaccine
The human papillomavirus (HPV) is the most common sexually
transmitted infection in the United States. (CDC, 2021) One in four U.S.
adults will be infected with HPV during their lifetime. (Chesson et al.,
2014) HPV incidence rises with increasing age and is highest among
individuals in their late teens and early twenties. (Viens et al., 2016)
Risk factors for HPV infection are associated with having a higher
number of lifetime sexual partners and initiating sex at a young age.
(Osazuwa-Peters et al., 2019) HPV causes virtually all cervical and anal
cancers, a majority of oropharyngeal and vaginal cancers, half of vulvar

cancers, and one-third of penile cancers. (Lowy and Schiller, 2012) HPV
also causes genital warts. (Park et al., 2015).
The HPV vaccine is recommended for adolescents between the ages
of 11 and 12 years, when immunogenicity is highest and previous
infection with HPV is rare. (Meites et al., 2019) While the vaccine is
approved for those up to age 45, (Food and Drug Administration, 2018)
the Advisory Committee on Immunization Practices (ACIP) recommends
vaccination through age 26. (Meites et al., 2019) Despite the safety and
efficacy of the HPV vaccine (Arbyn and Xu, 2018; St Laurent et al.,
2018), uptake has been suboptimal compared to other routine vacci
nations. (Elam-Evans et al., 2020) For young adults aged 18–26 years,
the HPV vaccine initiation rate is 39 % and the completion rate is 22 %.
(Boersma and Black, 2020).
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There is a small but growing body of evidence about HPV vaccine
acceptability and uptake in young adults ages 18 through 26. The
earliest studies focused on college students. (Daley et al., 2010; Patel
et al., 2012; Marchand et al., 2012) A more recent population-based
study of 18- to 26-year-olds found that men, those with a high school
diploma or less education, and those born outside the United States were
less likely to initiate and complete the HPV vaccine series. (Adjei Boakye
et al., 2018).
Understanding effective messages is crucial to vaccine uptake.
Numerous national organizations have campaigns to promote HPV
vaccination, typically focusing on parents. (American Cancer Society,
2019; Accelerating, 2014; The National, 2019; Academy, 2019) Mes
sages that appeal to young adults who are not parents will need to be
different than those created for parents. First, messages will need to
focus on vaccinating oneself rather than one’s child. Messages may stress
the sexually transmitted nature of the virus, which is salient for adults
but has been downplayed for parents. Vaccination messages for young
adults may have the look and feel of adult STI prevention campaigns,
which are often more blunt, edgier, and appealing to an adult audience.
(Parenthood and Tools, 2021).

RQ1: Do HPV videos with higher levels of narrative engagement
have a stronger effect on intentions to talk about the HPV vaccine
and be vaccinated against HPV than less engaging HPV videos?
RQ2: Do perceptions of the COVID pandemic moderate the effects of
video engagement on vaccine intention?
RQ3: Which social media ad campaign, and corresponding ad fea
tures, was most likely to lead to survey completion?
2. Methods
2.1. Overview
Our goal was to engage an audience of young adult women to watch
narrative-based videos addressing HPV vaccination and complete a
survey about their engagement with the videos, their intentions to talk
to others about HPV vaccination, and their own HPV vaccination in
tentions. We recruited via social media, where potential participants
saw a sponsored ad that we created for the study. Contained within the
ad was a link; clicking the link took participants to a randomly assigned,
narrative-based video on HPV vaccination. After watching the video,
participants completed a short survey. Participants were compensated
$10 via an electronic gift card for completing the survey. This study was
deemed exempt by the organization’s Institutional Review Board.

1.2. Theoretical Framework: A Narrative-Based approach to health
promotion
Narrative engagement theory (Miller-Day and Hecht, 2013) provides
a useful framework for message design to promote HPV vaccination.
(Hecht et al., 2021; Hopfer et al., 20182018; Hopfer and Clippard, 2011)
Miller-Day and Hecht define narrative as talk organized around signif
icant experiences, with characters undertaking action, within a context,
with implicit or explicit beginning and end points and significance for
the narrator or her or his audience. (Miller-Day and Hecht, 2013) Per
sonal narratives are culturally grounded and can provide valuable
insight into understanding health decisions. (Kreuter et al., 2007)
Translating those insights into prevention messages can be engaging and
effective, create more appealing messaging, and extend reach to low
awareness and/or resistant audiences (Miller-Day and Hecht, 2013;
Kreuter et al., 2007; Larkey and Hecht, 2010). Vaccine narratives
translated into an intervention can be particularly useful with people
who have difficulty understanding statistics used in health messages;
(Petraglia, 2007) provide modeling of behaviors enhancing self-efficacy;
(Miller-Day and Hecht, 2013) highlight the potential benefits of a health
behavior, targeting beliefs and norms about health behaviors; (Kreuter
et al., 2007) and be a vehicle to “re-story” or change an existing HPV
vaccination narrative to promote health behavior change. (Hecht et al.,
2021; De Oliveira et al., 2019; Gerend and Shepherd, 2012) Narrative
engagement theory predicts that narratives can provide the content for
vaccine messaging that is more likely to be relevant to and resonate with
young people (Hecht and Krieger, 2006; Hecht et al., 2009) and effec
tively engage an audience when considering health behavior. (MillerDay and Hecht, 2013; Larkey and Hecht, 2010; Gonzalez Cabreram and
Igartua, 2018).

2.2. Narrative-Based video intervention development
We used six narrative-based videos designed to increase HPV
vaccination rates among adult women (mean video length = 1 min, 24
s). These videos focused on vaccinating oneself rather than one’s child
and stressed the sexually transmitted nature of the virus and its link to
various cancers. The videos were evidence-based and part of the previ
ously developed “HPV Wellness Suite: Women’s Stories” HPV inter
vention. (Hecht et al., 2021; Hopfer et al., 20182018; Hopfer et al.,
2017) The videos have proven efficacious and are described elsewhere
in two clinic-based randomized clinical trials. (Hecht et al., 2021;
Hopfer, 2012) In general, this approach involves in-depth interviews to
solicit vaccine decision narratives, the details and events of these de
cisions serve as the foundation of the prototypical stories depicted in the
videos. (Larkey and Hecht, 2010) Health facts, positive modeling of the
behavior, and a call to action are then woven into the story. Descriptions
of the videos can be found in the Appendix. Copies of the video are
available upon request.
2.3. Social media advertisement development
To recruit participants on social media to complete the survey, we
created 15-second video ads that depicted mostly young women but
could appeal to all women, given that the vaccine is approved for
women up to age 45. The first video depicted general images of women
in a slideshow format. The second video depicted 18–26-year-old male
and female adults interacting with each other. The two video ads were
paired with two different messages: a statement, “The HPV Vaccine Has
Been Proven to Prevent Cancer in Women,” or a question, “Did you
know the HPV Vaccine Prevents Cancer in Women?” We also created
four static (single image) ads. The first two ads featured an image of a
young Asian adult female, while the second two ads featured an image of
a young African American adult female. The static ads were paired with
the same messages that were used in the video ads. Facebook reviews all
ads prior to distributing the ads across their platform. The third static
add was rejected because it was labeled a social issue. The team decided
not to pursue an advanced review and therefore it was not published.
The full set of ads are in Table 1.

1.3. Study purpose
The purpose of this social media-based intervention study was to test
whether variations in narrative engagement led to differences in HPV
vaccine intentions. While there is a growing evidence base of the impact
of interventions on social media, (Asare et al., 2021) this is one of the
first to be grounded in narrative engagement theory. We were interested
in recruiting as diverse of an audience as possible; hence, we used this
opportunity to simultaneously test the most effective messaging for
recruiting through social media. We proposed the following research
questions:

2.4. Recruitment
The study ran from August 12, 2020 through September 26, 2020 on
2

A.E. Leader et al.

Preventive Medicine Reports 29 (2022) 101920

Table 1
Campaign Creatives.

Instagram platforms (Feed, Explore, and Stories) using Facebook (FB)
Ad Manager. We chose Instagram platforms because 18–26-year-olds are
more likely to use Instagram rather than Facebook. (Pew Research
Center, 2021) We used the recruitment period as a time to test the
effectiveness of the ads on their ability to lead to completed surveys.
Those who had previously been vaccinated against HPV, determined
through self-report, were excluded from participating in the study.
Three different campaigns (ad + message) were conducted (Table 2). In
the first campaign, we tested the message framing (statement vs ques
tion) and kept the video constant. The ads were tested against each other
using the A/B Testing feature within FB Ad Manager. The second
campaign focused on testing two different images in combination with
either type of ad message (Table 1: Video Ads A & B vs C & D). For the
third campaign, we switched to the static ads and added primary text,
(“Learn more. Take a survey. Get an Amazon gift card on us.”). This

campaign was continued through the end of the study without any
further changes.
2.5. Survey measures
2.5.1. Engagement
The engagement variable measurement assessed interest, realism,
and identification. (Lee et al., 2011) Items were measured on Likert-type
scale (1 = strongly disagree; 5 = strongly agree). Interest items included,
“The video was interesting,” “I paid attention to the video,” “when
watching the video, I did NOT think about other things,” “I had a hard
time keeping my mind on the video” (reverse coded), “If this video was
available on Instagram, I would share it,” and “The video was boring”
(reverse coded). Realism items consisted of, “The video seemed realistic
to me” and “the video was believable.” Identification items were, “The

Table 2
Facebook Analytic Data for Each Campaign.
Campaign

I
(Message Testing)

II
(Image Testing)

III
(Message and Image Testing)

Dates

8/12 – 8/23

8/25 – 8/29

Creatives Used
Reach

A
A: 8,741

B
B: 7,527

A
A: 8,732

B
B: 4,964

C
C: 5,006

D
D: 5,244

Static Ad 1
1: 21,416

Static Ad 2
2: 6,666

Static Ad 4
4: 15,317

Impression

A: 10,115

B: 8,841

A: 10,535

B: 5,733

C: 5,851

D: 6,123

1: 29,355

2: 7,741

4: 19,243

Video Percentage Watched:

A: 6.7%

B: 6.1%

A: 5.25%

B: 5.74%

C: 6.65%

D: 6.84%

–

–

–

Link Clicks (Unique Link Clicks):

A: 18 (18)

B: 25 (25)

A: 13 (13)

B: 20 (20)

C: 12 (11)

D: 15 (15)

1: 515 (412)

2: 248 (215)

4: 771 (623)

Number of Completed Surveys
Cost per Result

3
A: $1.33

B: $0.96

1
A: $1.86

B: $0.78

C: $1.67

D: $1.32

987
1: $0.61

2: $0.57

4: $0.59

8/25 – 8/29

*Ad 3 was rejected by Facebook.
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people in the video seemed like people I know” and “The people in the
video seemed like me.” This scale obtained a reliable Cronbach alpha (α
= 0.85, M = 3.78, SD = 0.60).

averaged about $0.59 per link click ($0.92 per completed survey).

2.5.2. Dependent variables
Dependent variables identified participants’ intentions to talk with a
healthcare provider or their friends or family about the vaccine or to
receive the HPV vaccine the next time they visited their doctor. Each
item was measured as a single item on a 5-point Likert-type scale (1 =
very unlikely, 5 = likely). Items included, “I intend to talk with my
healthcare professional about the HPV vaccine” (M = 3.86; SD = 1.04),
“I intend to talk to my friends/family about the HPV vaccine” (M = 3.62;
1.14; SD = 1.14), and “I intend to get the HPV vaccine the next time I see
my doctor” (M = 3.68; SD = 1.10).

Across all ad campaigns, 1332 link clicks led to 991 completed sur
veys and 607 usable surveys (Fig. 1). A full description of the 607 par
ticipants is in Table 3. Most participants (n = 579, 95.4 %) were between
the ages of 18–26, 23 (3.8 %) were 27–34, and 5 (0.8%) were between
the ages of 35–45. The sample was diverse with 226 (37.2 %) who
identified as white/Caucasian, 160 (26.4 %) Asian/Asian American, 88
(14.5 %) Hispanic/Latino/Latina, and 59 (9.7 %) Black/African Amer
ican. The number of participants who were randomized to each

3.2. Participants

2.5.3. Moderating variable
To address Research Question 2, to understand if perceptions of the
COVID-19 pandemic moderated the effects of video engagement on
vaccine intention, the covariate regarding COVID-19 “COVID has
impacted my decision to get the HPV vaccine” (M = 2.91, SD = 1.27)
was measured on a Likert-type scale (1 = strongly disagree, 5 = strongly
agree).
2.6. Data management and statistical analysis
Surveys were deployed through Qualtrics, where data was collected
and stored as a secure datafile. To test differences in engagement and
intentions by video, we used a two-tailed Pearson correlation and an
analysis of variance (ANOVA). Research Question 2, that perceptions of
the COVID-19 pandemic (“COVID has impacted my decision to get the
HPV vaccine”) would moderate the effect of video engagement on
vaccine intentions, was answered using Model 1 from the PROCESS
macro in SPSS. (Hayes, 2018) Models used percentile bootstrapped
standard errors and 95 % confidence intervals from 5,000 resamples to
examine the indirect effects. Continuous variables were standardized
before being entered into the model, making coefficients partially
standardized. Confidence intervals not containing zero were interpreted
as statistically significant.
2.7. Social media campaign analytics
Campaign ad performance was measured by using a number of
metrics that were available through Facebook’s Ad Manager. ‘Reach’
was used to track the number of Instagram users who saw the ads at least
once. ‘Impressions’ measured the number of times our ads were on
screen, which included multiple views by the same user. ‘Link clicks’ and
‘unique link clicks’ were used as the main metric for measuring per
formance and included any Instagram user that clicked on the link in our
ads. Cost per result indicated the cost per link click based on the total
amount spent on the campaign. Research Question 3, which ad and ad
features led to the greatest number of completed surveys, was deter
mined by a frequency count of the number of surveys completed stem
ming from each ad.
3. Results
3.1. Social media campaign (RQ3)
The results of the four campaigns can be seen in Table 2. In the first
campaign, we found no differences in the number of link clicks between
the two video ads. We found that 43 link clicks translated into 3
completed surveys (Table 2). A/B testing showed no difference between
the type of message (statement vs question) used in the campaign. The
second campaign with video ads resulted in 1 additional completed
survey from 59 link clicks. After the change to static ads, the third and
final campaign resulted in 987 surveys from 1,250 link clicks and

Fig. 1. CONSORT Diagram.
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= 0.00) (Table 5).

Table 3
Participant Demographics.
Demographic
Gender
Female
Age
18–26
27–34
35–45
Ethnicity
White/Caucasian
Asian/Asian American
Hispanic/Latino/Latina
Black/African American
More than one ethnicity
Other
Sexual Activity
Sexually active in the past 3 months
Not sexually active in the past 3 months

N

%

3.4. Moderation (RQ2)

607

100

579
23
5

95.4
3.8
0.8

226
160
88
59
39
35

37.2
26.4
14.5
9.7
6.4
5.8

Results of a moderation analysis indicated that “COVID has impacted
my decision to get the HPV vaccine” (M = 2.91, SD = 1.27) (Table 4) and
the overall model (i.e., perceptions of the COVID-19 pandemic moder
ating the relationship between engagement and intentions) was signif
icant, F (3, 603) = 60.32, p <.001, R2 = 0.23. However, the interaction
effect between engagement and the impact that COVID-19 has on vac
cine intentions was not significant B = -0.07, SE = 0.05, t = -1.49, p
=.14, 95 % CI [-0.17, 0.02]. (Fig. 2). Thus, COVID appears to have an
independent but not moderating effect on the engagement to intentions
pathway.

353
254

58.2
41.8

4. Discussion
The purpose of this study was threefold: to determine if videos with
higher levels of engagement had higher levels of intention to talk with
someone about the vaccine or to be vaccinated, to determine if certain
videos resonated more strongly with young adults recruited through
social media, and to determine if perceptions about the COVID-19
pandemic would impact intentions to vaccinate against HPV.
First, we found that overall videos that scored higher on engagement
evoked stronger intentions to vaccinate. This is consistent with, but an
extension of, previous research conducted with the WS video interven
tion. For example, Rey et al. reported comparable levels of engagement
and a strong association between engagement and video persuasiveness,
but did not evaluate vaccination intentions. (Rey et al., 2021) Hecht
et al. measured the effects of a clinic based WS video intervention on
vaccine intentions and vaccine self-efficacy and found significant posi
tive intervention effects on each, but did not examine engagement with
the intervention videos. (Hecht et al., 2021) Promisingly, when looking
at the effect of all videos across participants, there was an association
between video exposure and vaccine intentions. This confirms pre
dictions from Narrative Engagement Theory about the types of videos
that are effective in promoting behavior change.
The findings from this study also have implications for promoting
research studies on social media. First, we found that static ads were
more effective than video clips in attracting our audience to the study.
This may be the nature of the social media environment, where people
are rapidly viewing large quantities of content and do not intend to view
any one post for a substantial amount of time. Being able to move
quickly to the study rather than watching a short video was preferred for
our audience of young adults. We also confirmed that recruiting through
social media led to diverse representation of participants. In our sample,
about two-thirds of participants identified with a racial or ethnic

narrative engagement video ranged from 93 (Video 5) to 107 (Video 2).
3.3. Dependent variables (RQ1)
Engagement scores for each of the six videos ranged from the lowest
at 3.62 (SD = 0.65) for Video 2 to the highest at 3.89 (SD = 0.60) for
Video 1 (Table 4). Engagement scores were significantly higher for
Video 1 and Video 5 compared to Video 2. (Table 5).
Across all videos, the mean score was highest for “I intend to talk
with my healthcare professional about the HPV vaccine” (M = 3.89, SD
= 1.02) and lowest for “I intend to talk to my friends/family about the
HPV vaccine” (M = 3.65, SD = 1.12). The mean score for “I intend to get
the HPV vaccine the next time I see my doctor” was 3.71 (SD = 1.08).
(Table 4).
Results of a two-tailed Pearson correlation to test whether videos
with a higher narrative engagement had stronger effects on intentions
indicated that engagement was positively associated with intentions to
talk with a healthcare professional about the HPV vaccine (r = 0.44, p
=.01) and intentions to talk to friends/family about the HPV vaccine (r
= 0.52, p =.01). Results of a two-tailed Pearson correlation indicated
that there was also a positive relationship between engagement and
intentions to vaccinate (r = 0.43, p =.01). Therefore, the hypothesis was
supported (Table 6). When examining if there was a significant differ
ence in any of the intention variables between the different videos, the
ANOVA was not significant for any of them: “I intend to talk with my
healthcare professional about the HPV vaccine” F(5, 601) = 0.51, p
=.77, (η2 = 0.004), “I intend to talk to my friends/family about the HPV
vaccine” F(5, 601) = 0.98, p =.43, (η2 = 0.008), and “I intend to get the
HPV vaccine the next time I see my doctor” F(5, 601) = 0.73, p =.60, (η2
Table 4
Mean Scores of Each Video on Key Outcome Measures.
Video
Composite
Score
N
Engagement*
(α = 0.85)
I intend to talk to healthcare professional about the HPV
vaccine
I intend to talk to friends/family about the HPV vaccine
I intend to get the HPV vaccine the next time I see my doctor
Covid-19 has impacted my decision to get the HPV vaccine

1

2

100

3

107

4

102

5

111

6

93

94

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

M

SD

3.78

0.60

3.89

0.6

3.62

0.65

3.78

0.58

3.82

0.59

3.88

0.51

3.81

0.65

3.54

0.92

3.88

1.09

3.85

0.99

4.03

0.96

3.86

0.89

3.83

1.07

3.9

1.13

3.65
3.71
2.91

1.12
1.08
1.27

3.55
3.63
2.85

1.25
1.19
1.27

3.63
3.75
3.09

1.12
1.00
1.21

3.85
3.84
3.34

0.97
1.03
1.35

3.67
3.63
2.76

0.97
1.04
1.23

3.56
3.62
2.82

1.17
1.06
1.28

3.61
3.76
2.87

1.25
1.18
1.25

Note: Video 1: Young Woman at Clinic; Video 2: African American Provider-Patient Caucasian woman; Video 3: Women’s Stories Truck; Video 4: Mom Daughter
Kitchen; Video 5: Young Adult Overview; Video 6: Benefits of vaccination.
*Engagement is a summary score of all the engagement items.
5
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Table 5
Differences in Engagement and Intentions by Video.
n

Engagement*
(M, SD)

I intend to talk with my healthcare
professional about the HPV vaccine
(M, SD)

I intend to talk to my
friends/family about the
HPV vaccine
(M, SD)

I intend to get the HPV
vaccine the next time I see
my doctor
(M, SD)

I intend to share the
Instagram post
(M, SD)

107

2.91
0.01
0.02
3.89, 0.60

0.51
0.77
0.004
3.88, 1.9

0.98
0.43
0.008
3.63, 1.12

0.73
0.6
0.006
3.75, 1.00

0.25
0.94
0.004
2.96, 1.34

111

3.62, 0.65

3.86, 0.89

3.67, 0.97

3.63, 1.04

2.86, 1.22

102

3.78, 0.58

4.03, 0.96

3.85, 0.97

3.84, 1.03

3.02, 1.23

94

3.82, 0.59

3.90, 1.13

3.62, 1.25

3.76, 1.18

2.86, 1.24

93
100

3.88, 0.51
3.81, 0.65

3.83, 1.97
3.88, 1.09

3.56, 1.17
3.55, 1.25

3.62, 1.06
3.63, 1.19

2.97, 1.33
2.91, 1.25

F
p

η2

Video 1: ProviderPatient Story at
Clinic #1
Video 2: MotherDaughter Story
Video 3: Rural
Location Story
Video 4: Story
Montage #1
Video 5: Montage #2
Video 6: ProviderPatient Story at
Clinic #2

* Summary Score of Engagement Items.

et al., 2019) The public health and medical communities have a re
sponsibility to counterbalance this information in a way that is engaging
and credible to audiences. It is not enough to assume that the visibility
on social media is enough to inspire change in its viewers. Indeed,
considering how anyone posting on social media must jockey for space
with an almost-limitless number of other posts, which may contain
misinformation, any credible, pro-vaccine message must stand out. Ads
like the ones we created, as well as videos such as the HPV Wellness Suite:
Women’s Stories, can reverse this trend by providing high-quality,
factually accurate information on social media. Moreover, the results
of the study can inform future public health initiatives to increase HPV
vaccination among an older age group, those over the age of 18, who are
making vaccination decisions for themselves rather than relying on a
parent.
While there were numerous strengths to this study, such as using a
theoretically grounded, evidence-based video intervention, there were
limitations. Due to the nature of the study, we were unable to measure
actual HPV vaccination behavior. While self-report of HPV vaccination
status has been shown to be an acceptable measure of actual vaccination
behavior, (Yamaguchi et al., 2018; Rolnick et al., 2013) and was most
feasible in this study, it is not error-free. There may also be a social
desirability bias to over-report intentions or positive attitudes toward
vaccination. We only posted on Facebook-based platforms and are un
able to generalize these findings to other social media platforms. It
should be noted that Facebook Ad Manager does not provide individual
level analytic data. The study was designed to appeal to young women; it
is unclear whether a similar type of study and intervention would appeal
to young men, who are also eligible for HPV vaccination. Last, while we
saw significant differences in engagement between videos, the differ
ences were small and may not be conceptually meaningful. The varia
tion in responses was also small and may be indicative of a homogeneous
sample of participants who already had positive views of the HPV vac
cine. Nevertheless, this study lays the foundation for future research and

Table 6
Correlation Matrix for Engagement and Intention Items.
1. Engagement*
2. I intend to talk with my healthcare
professional about the HPV vaccine
3. I intend to talk to my friends/family about
the HPV vaccine
4. I intend to get the HPV vaccine the next
time I see my doctor

1

2

–
0.442**

3

–

0.516**

0.626**

–

0.431**

0.757**

0.554**

4

–

*Summary score of all engagement items.
**Correlation is significant at the 0.01 level (2-tailed).

minority group. This is reflective of other studies that have had success
in recruiting diverse participant samples through social media. (Whi
taker et al., 2017).
Our study also contributes to knowledge about perceptions of
vaccination during COVID-19. Access to preventive care, like the HPV
vaccine, was halted in many communities, resulting in steep declines in
routine vaccination. (Findling et al., 2020; Patel Murthy et al., 2021) We
wondered if perceptions of the COVID pandemic moderated the effects
of video engagement on vaccine intention. The findings of this study
suggest that perceptions about COVID-19 did not moderate the effects of
the intervention on intentions to vaccinate. This illustrates that the
COVID-19 pandemic has not impacted the HPV vaccination decisionmaking process. Even as the COVID-19 pandemic continues, primary
care physicians, as well as other health care professionals such as
pharmacists, should continue to have conversations with their patients
about the importance of being vaccinated against HPV.
It is important to still be vigilant when promoting HPV vaccination.
Currently, social media is a breeding ground for misinformation and
disinformation, particularly as it relates to health information. (Wang

Fig. 2. Model 1 Conceptual Diagram.
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interventions that aim to promote HPV vaccination on social media, in
understanding how to reach key and diverse audiences with messages
that are both credible and engaging.

unpacking their truck during the summer as they prepare to go to the
river in a rural town. One girl is a current soccer coach who had a
doctor’s appointment that morning for her TB shot when her doctor
mentioned the HPV vaccine. The second girl asks, “What’s that?” and
the initial actress responds by explaining the caners related to HPV and
the number of shots you must receive as an adult to become vaccinated.
The friend then discloses “My uncle had oral cancer and it was bad.
Maybe I should look into getting the shot.” The girl supports her friend
and says, “being protected from cancer is totally worth it.” Tag lines:
“Don’t wait to vaccinate.” “Protect yourself from HPV-related cancers.”
“Protect your partner too.”.
Video 4: Story Montage #1 – 2 min, 16 s. This video includes a
montage of HPV vaccine decision stories from the point of view of two
ethnically diverse fathers and teenage sons and two ethnically diverse
mothers and teenage daughters. Two ethnically diverse healthcare
providers offer counter arguments and health information about HPV,
cancer, vaccine safety, and numbers of shots in the series. Tag line: “Ask
your doctor about HPV vaccination.”.
Video 5: Montage #2 – 48 s. In this short video, a series of young
adult men and women address the camera providing information about
HPV, HPV-related cancers, and the HPV vaccination. Tag lines: “Don’t
wait to vaccinate,” “Protect yourself against HPV-related cancers,” and
“Protect your partner too.”.
Video 6: Provider-Patient Story at Clinic #2 – 1 min, 39 s. This video
consists of one Latina woman in her early 20′ s discussing HPV vacci
nation with her Caucasian female healthcare provider. The young
woman explains that her mother didn’t approve of the HPV vaccine.
When asked “Why?” she gets embarrassed, laughs and says, “Well, I
don’t think that she likes the idea of me having sex.” The physician di
rects the young woman to discuss her own understanding of the vaccine
and then provides information about protection against HPV-related
cancers. The young woman invokes her mother’s concerns again and
saying that the vaccine is “too new.” The physician again provides a factbased rebuttal to this, discusses the safety of the vaccine, and calls upon
her own role as mother saying that “in fact, I had my 11-year-old
daughter vaccinated just last month. I wouldn’t give it to my daughter
unless it was safe.” The scene ends with the young woman agreeing to
receive the vaccine during the visit. Tag lines: “Ask your doctor about
HPV,” “Tell your friends to ask their doctors,” and “Protect yourself
against cervical, oral and anal cancer by vaccinating against HPV.”.
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Appendix
HPV Story Descriptions.
Video 1: Provider-Patient Story at Clinic #1 – 1 min, 8 s. This video
includes one Caucasian woman in her early 20′ s discussing HPV vacci
nation with her Black female healthcare provider. The young woman
admits to being sexually active but not concerned about HPV because
she only has one partner. The physician discusses how she can still
contract HPV. The patient then asks. “don’t people usually get the
vaccine when they are kids?” and the physician admits that this is the
case but that if not already vaccinated, the HPV vaccine is recommended
for or all sexually active adults of the patient’s age. The physician
strongly recommends vaccination, and we finish with the tag lines: “Ask
your doctor about HPV,” “Tell your friends to ask their doctors,” and
“Protect yourself against cervical cancer by vaccinating against HPV.”.
Video 2: Mother-Daughter Story – 1 min, 17 s. This video consists of
one Latina daughter in her early 20′ s and her Latina mother in her 40′ s.
The daughter enters the kitchen where her mother is sitting at the
kitchen table and asks, “Why do you look so sad?” The mother replies
that “Tia (Aunt) Maria” was diagnosed with cervical cancer due to HPV.
After empathizing with her mother, the daughter points out that she just
learning about the HPV vaccine in her college class. They move on to
discuss the safety of the vaccine and the daughters desire to receive the
vaccine. Towards the end, the mother reconsiders her position about
non-vaccination.
Video 3: Rural Location Story – 1 min, 18 s. This video includes two
Caucasian female friends who are high school seniors. They are
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